Form 4: SOPHIA GENETICS SA: Insider Sells Shares for Tax Withholding

SOPHIA GENETICS SA reports that President Ross Muken sold shares to cover tax obligations related to vested restricted stock units, executed under a Rule 10b5-1 trading plan.

Summary

• President Ross Muken of SOPHiA GENETICS SA sold a total of 4,736 ordinary shares across two transactions on April 8th and April 9th, 2026.
• These sales were conducted to satisfy tax withholding obligations arising from the vesting of restricted stock units.
• The transactions were executed under a pre-established Rule 10b5-1 trading plan, indicating they were not discretionary.
• The first sale on April 8th involved 2,786 shares at a weighted average price of $4.8414.
• The second sale on April 9th involved 1,950 shares at a weighted average price of $4.7379.
• Following these transactions, Ross Muken beneficially owns 693,361 ordinary shares directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While it involves insider selling, the clear explanation of tax withholding obligations and the use of a Rule 10b5-1 plan mitigate concerns about negative sentiment.

Positives

• The sales were conducted under a Rule 10b5-1 trading plan, which is designed to comply with insider trading regulations and demonstrates pre-planned financial management.
• The sales were specifically to cover tax withholding obligations, a common and expected event for executives receiving equity compensation.

Negatives

• Insider selling, even for tax purposes, can sometimes be perceived negatively by the market, although the Rule 10b5-1 plan mitigates this concern.
• The weighted average sale prices indicate a slight decrease in value from the first to the second day of transactions.

Risks

• While these specific sales are routine, any significant or unexpected insider selling could signal a lack of confidence in future stock performance.
• The company's stock price could be affected by market perception of insider transactions, regardless of the stated reason.

Future Outlook

This filing does not contain forward-looking statements or guidance. It solely reports on past transactions.

Management Comments

• Sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.
• The sales were made to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard for reporting insider transactions. The use of a Rule 10b5-1 plan by SOPHiA GENETICS SA's President is a common practice for executives to manage their equity holdings and comply with trading regulations, especially when dealing with tax obligations from equity awards.

Stakeholder Impact

• Shareholders: The sales are pre-planned and for tax purposes, so the direct impact on share price is expected to be minimal, though market perception can vary.
• Employees: The transaction highlights the equity-based compensation structure for executives.
• Management: Demonstrates adherence to regulatory requirements and sound financial planning for personal equity holdings.

Next Steps

• Continued monitoring of insider transactions for any deviations from established plans or significant changes in beneficial ownership.
• Future vesting events for restricted stock units may lead to similar transactions if tax obligations remain.

Key Dates

Keywords

SOPH, Insider Trading, Form 4, Rule 10b5-1, Stock Sale, Tax Withholding, Restricted Stock Units, Executive Compensation, Beneficial Ownership, SOPHiA GENETICS SA